Meeting
2015 Genitourinary Cancers Symposium
Germ line predictors of response to androgen deprivation therapy in men with advanced prostate cancer.
Authors
Neeraj Agarwal
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Neeraj Agarwal , Tyler Howard Buckley , Jim M. Farnham , Shiven B. Patel , Anitha Alex , Craig Teerlink , Frederick S. Albright , Robert A Stephenson , Lisa A Cannon-Albright
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 162)
DOI
10.1200/jco.2015.33.7_suppl.162
Abstract #
162
Poster Bd #
G24
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Socio-demographic, clinical, and genetic predictors of low versus high Gleason score among men with prostate cancer in the Detroit Research on Cancer Survivorship (ROCS) cohort.
First Author: Samantha Goodenow
Poster
2016 Genitourinary Cancers Symposium
Association of single nucleotide polymorphism in four genes and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive prostate cancer (aHSPC).
First Author: David Gill
Poster
2015 Genitourinary Cancers Symposium
Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).
First Author: Samith Thomas Kochuparambil
Poster
2024 ASCO Genitourinary Cancers Symposium
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy (iADT) with relugolix.
First Author: Patrick Campbell